INTEGRA LIFESCIENCES HOLDINGS CORP Interest Expense Nonoperating
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Interest Expense Nonoperating of $22.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for the quarter ending 2026-06-30 was $22.99M, a 9.28% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for the quarter ending 2026-03-31 was $22.46M, a 19.40% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for the quarter ending 2025-12-31 was $23.67M, a 24.70% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for the quarter ending 2025-09-30 was $22.73M, a 17.30% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for fiscal 2025 was $86.25M, a 22.12% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for fiscal 2024 was $70.63M, a 37.48% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for fiscal 2023 was $51.38M, a 3.60% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP interest expense nonoperating for fiscal 2022 was $49.59M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.99M 10-Q · filed 2026-07-29 | $45.46M 10-Q · filed 2026-07-29 | $69.13M derived: sum of 3 quarters · filed 2026-07-29 | $91.86M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $22.46M 10-Q · filed 2026-05-05 | $46.14M derived: sum of 2 quarters · filed 2026-05-05 | $68.86M derived: sum of 3 quarters · filed 2026-05-05 | $89.91M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $23.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $46.40M derived: sum of 2 quarters · filed 2026-02-26 | $67.44M derived: sum of 3 quarters · filed 2026-07-29 | $86.25M 10-K · filed 2026-02-26 |
| 2025-09-30 | $22.73M 10-Q · filed 2025-10-30 | $43.77M derived: sum of 2 quarters · filed 2026-07-29 | $62.58M 10-Q · filed 2025-10-30 | $81.57M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $21.04M 10-Q · filed 2026-07-29 | $39.86M 10-Q · filed 2026-07-29 | $58.84M derived: sum of 3 quarters · filed 2026-07-29 | $78.21M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $18.82M 10-Q · filed 2026-05-05 | $37.80M derived: sum of 2 quarters · filed 2026-05-05 | $57.17M derived: sum of 3 quarters · filed 2026-05-05 | $75.82M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $18.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.36M derived: sum of 2 quarters · filed 2026-02-26 | $57.01M derived: sum of 3 quarters · filed 2026-02-26 | $70.63M 10-K · filed 2026-02-26 |
| 2024-09-30 | $19.37M 10-Q · filed 2025-10-30 | $38.02M derived: sum of 2 quarters · filed 2025-10-30 | $51.65M 10-Q · filed 2025-10-30 | $65.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $18.65M 10-Q · filed 2025-07-31 | $32.27M 10-Q · filed 2025-07-31 | $46.03M derived: sum of 3 quarters · filed 2026-02-26 | $59.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $13.62M 10-Q · filed 2025-05-05 | $27.38M derived: sum of 2 quarters · filed 2026-02-26 | $40.44M derived: sum of 3 quarters · filed 2026-02-26 | $52.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $13.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.81M derived: sum of 2 quarters · filed 2026-02-26 | $39.28M derived: sum of 3 quarters · filed 2026-02-26 | $51.38M 10-K · filed 2026-02-26 |
| 2023-09-30 | $13.06M 10-Q · filed 2024-11-04 | $25.53M derived: sum of 2 quarters · filed 2024-11-04 | $37.63M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $12.46M 10-Q · filed 2024-07-29 | $24.56M 10-Q · filed 2024-07-29 | ||
| 2022-12-31 | $49.59M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |